MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0019075
Neuroequilibrium Diagnostic Systems Private Limited - healthcare in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.77 Cr
▲ 78% YoY
Net loss · FY 2024
₹6.09 Cr
Net margin -34.3%
EBITDA · FY 2024
-₹3.76 Cr
EBITDA margin -21.2%
Authorised capital
₹1.55 Cr
Registered with MCA
Paid-up capital
₹4.21 Lakh
Issued & subscribed
Satisfied charges
₹1.25 Cr
No open charges
Company age
11 yrs
Est. 2015
Employees · EPFO
97
Provident fund records
About Neuroequilibrium Diagnostic Systems Private Limited
Data last updated:
Neuroequilibrium Diagnostic Systems Private Limited is a private limited company based in Jaipur, Rajasthan, India, a subsidiary of Futurecure Health Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33110RJ2015PTC047281. Its GSTIN is 08AAECN8968M1ZJ (Rajasthan).
The company has an authorised share capital of ₹1.55 Cr and a paid-up capital of ₹4.21 Lakh. It is led by directors Rajneesh Bhandari (Managing Director) and Anita Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 140 Shri Gopal Nagar Gopalpura Byepass Road, Jaipur, Rajasthan, India – 302015.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.77 Cr, a growth of 78% compared to the previous year. For the same year it recorded a net loss of ₹6.09 Cr (net margin -34.3%) and EBITDA of -₹3.76 Cr (EBITDA margin -21.2%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years and 64% over five years.
The company has about 97 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: NeuroEquilibrium. As per MCA filings, the company has satisfied charges of ₹1.25 Cr on record. The company has 7 deals on record (3 secondary share transfers, 2 rights issues, 1 convertible or debt financing), with disclosed funding of ₹6.5 Cr; the latest was in March 2024.
Neuroequilibrium Diagnostic Systems Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0019075). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neuroequilibrium.in.
Company details
CIN U33110RJ2015PTC047281
Registration Number 047281
Incorporation Date 28 March 2015
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Futurecure Health Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-RJ-17-0019075
Recognitions & Rankings of Neuroequilibrium Diagnostic Systems
Contact details
Neuroequilibrium Diagnostic Systems Private Limited's registered office is in Jaipur, Rajasthan. Its website is neuroequilibrium.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address140 Shri Gopal Nagar Gopalpura Byepass Road, Jaipur, Rajasthan, India – 302015
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Comprehensive company report
Neuroequilibrium Diagnostic Systems Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Neuroequilibrium Diagnostic Systems operates one associated brand: NeuroEquilibrium. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic systems for vertigo and balance disorders are developed. | neuroequilibrium.in |
Business activity
The main business activities of Neuroequilibrium Diagnostic Systems are manufacturing and hospital and medical care. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities and medical and dental practice, nursing, pathology, blood bank services, etc.. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | |
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Financials of Neuroequilibrium Diagnostic Systems Private Limited
FY 2025 filings availableNeuroequilibrium Diagnostic Systems Private Limited reported revenue of ₹17.77 Cr (up 78% YoY) for FY 2024.
Revenue · FY 2024
₹17.77 Cr ▲ 78%
Net loss · FY 2024
₹6.09 Cr margin -34.3%
EBITDA · FY 2024
-₹3.76 Cr margin -21.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 64%
5 years · compounded
▲ 64%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 42%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 64% over five years, including 78% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.2% | ||||
| Net Profit Margin | -34.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Board of directors of Neuroequilibrium Diagnostic Systems Private Limited
Neuroequilibrium Diagnostic Systems has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Bhandari Also directs: Futurecure Health Private Limited | Director | 28 Aug 2020 | 6 Years 1 Months | Current |
| Rajneesh Bhandari Also directs: Greend Technologies LLP, NRN Infrasolutions LLP, Sigma Carbon Technologies LLP and 4 more | Managing Director | 28 Mar 2015 | 11 Years 6 Months | Current |
Auditor
Neuroequilibrium Diagnostic Systems Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2023 | 001076N/N500013 |
Shareholding
The shareholding of Neuroequilibrium Diagnostic Systems Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2021 | 100483201 | Others | ₹1.25 Cr | Satisfied |
To see the full charge records of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Neuroequilibrium Diagnostic Systems Private Limited has 7 deals on record (3 secondary share transfers, 2 rights issues, 1 convertible or debt financing), with disclosed funding of ₹6.5 Cr; the latest was in March 2024.
Total deals
7
Secondary share transfers
3
Rights issues
2
Convertible or debt financing
1
Funding round
1
Disclosed funding
₹6.5 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Rights issue | ₹8 Cr | Investors: Futurecure Health Private Limited |
| Mar 2023 | Rights issue | ₹15 Cr | Investors: Futurecure Health Private Limited |
| Jan 2021 | Funding round | ₹5 Cr | Investors: Futurecure Health Private Limited |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Unicorn India Ventures |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: Futurecure Health Private Limited Seller: Unicorn India Ventures, 2 individuals |
To see the full deal history of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Neuroequilibrium Diagnostic Systems Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neuroequilibrium Diagnostic Systems Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neuroequilibrium Diagnostic Systems Private Limited has a workforce of 97 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
97
Active EPFO establishments
1
GST
Neuroequilibrium Diagnostic Systems has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECN8968M1ZJ | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Neuroequilibrium Diagnostic Systems Private Limited, buy the company report.
Recent activity
Neuroequilibrium Diagnostic Systems Private Limited has 7 board changes on record since 2015: 2 appointments and 5 cessations. The latest: Anil Rambilash Joshi ceased to be Nominee Director on 18 Sep 2024.
AGM
Neuroequilibrium Diagnostic Systems Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neuroequilibrium Diagnostic Systems Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Anil Rambilash Joshi ceased to be Nominee Director.
Ceased
Rajneesh Bhandari ceased to be Director.
Charges
A charge registered on 06 Sep 2021 via Charge ID 100483201 with Others was fully satisfied on 17 Mar 2022.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100483201 was registered on 06 Sep 2021.
Ceased
Anita Bhandari ceased to be Additional Director.
Ceased
Gaurav Bhandari ceased to be Director.
Appointed
Anita Bhandari was appointed as Director.
Ceased
Jayanti Biswas ceased to be Director.
Appointed
Rajneesh Bhandari was appointed as Managing Director.
Incorporation
28 Mar 2015
Neuroequilibrium Diagnostic Systems Private Limited was registered on 28 Mar 2015 with Roc Jaipur & aged 11 years 6 months as per MCA records.
News
Frequently asked questions
Neuroequilibrium Diagnostic Systems is an active private limited company based in Jaipur, Rajasthan, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 March 2015 (11+ years old) and is registered under CIN U33110RJ2015PTC047281.
Neuroequilibrium Diagnostic Systems has 2 current directors:
- Rajneesh Bhandari - Managing Director
- Anita Bhandari - Director
The latest financial statements of Neuroequilibrium Diagnostic Systems on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Neuroequilibrium Diagnostic Systems is 08AAECN8968M1ZJ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Neuroequilibrium Diagnostic Systems is U33110RJ2015PTC047281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neuroequilibrium Diagnostic Systems was incorporated on 28 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.
Neuroequilibrium Diagnostic Systems has 7 deals on record (3 secondary share transfers, 2 rights issues, 1 convertible or debt financing), with disclosed funding of ₹6.5 Cr; the latest was in March 2024.
Anil Rambilash Joshi ceased to be Nominee Director on 18 Sep 2024. Rajneesh Bhandari ceased to be Director on 31 Aug 2022. Anita Bhandari ceased to be Additional Director on 29 Dec 2020. Neuroequilibrium Diagnostic Systems has 7 board changes on record in total.
Yes, Neuroequilibrium Diagnostic Systems is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-17-0019075).
Neuroequilibrium Diagnostic Systems can be reached through the website neuroequilibrium.in. Its registered office is in Jaipur, Rajasthan, India.